Piper Sandler Maintains Neutral on Elanco Animal Health, Raises Price Target to $13
Portfolio Pulse from jenniferd'souza@benzinga.com
Piper Sandler analyst David Westenberg maintains a Neutral rating on Elanco Animal Health (NYSE:ELAN) and raises the price target from $9 to $13.
August 14, 2023 | 1:35 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Piper Sandler maintains a Neutral rating on Elanco Animal Health and raises the price target from $9 to $13. This could potentially attract investors.
The raised price target by Piper Sandler indicates a positive outlook for Elanco Animal Health. This could potentially attract investors and influence the stock price to go up in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100